Delivery Order SPE2DB25D3020-SPE2DB25FWJPF
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes valued at $9,034.57 under a firm fixed price contract type. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency (DLA) awarded a $2,816.86 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of 4,565,699,051 units of the ENGERIX-B 20 MCG/ML SYRNML vaccine. This delivery order was placed against an Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for providing pharmaceutical and medical supplies to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,496.37, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The order has an ultimate completion date of April 20, 2023 and was awarded on April 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,796.56 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,565,744,243 units of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The delivery order has a ceiling value of $20,922.80 and an ultimate completion date of October 16, 2024. The contract utilizes firm fixed pricing and does not have a set-aside designation. AmerisourceBergen, through its extensive supply chain and distribution...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,890.02 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine products. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML vaccine. The contract has a firm fixed price of $7,007.60 and an ultimate completion date of July 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
- This is a $1,298.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for ENGERIX-B 20 MCG/ML SYRNML, a vaccine product, with a performance period ending on May 23, 2025. The contract is not set-aside and is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive...
- The Defense Logistics Agency awarded a $7,410.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B 20 MCG/ML SYRNML. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pediatric hepatitis B vaccines. Amerisourcebergen will deliver the vaccines from its facility in Conshohocken, Pennsylvania by September 14, 2023 to support the Department of Defense's immunization programs. No subcontractors or set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The total ceiling value of the order is $1,354.96, with a period of performance through March 19, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded to...